Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trials

Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trials

Abstract Introduction Several studies suggest that luteinizing hormone (LH) could improve IVF outcome in women of advanced reproductive age by optimizing androgen production. In this review, we assessed the role of recombinant-human LH (r-hLH) and recombinant human follicle stimulating hormone (r-hF...

Full description

Bibliographic Details
Main Authors: Alessandro Conforti, Sandro C. Esteves, Peter Humaidan, Salvatore Longobardi, Thomas D’Hooghe, Raoul Orvieto, Alberto Vaiarelli, Danilo Cimadomo, Laura Rienzi, Filippo Maria Ubaldi, Fulvio Zullo, Carlo Alviggi
Format: Article
Language:English
Published: BMC 2021-06-01
Series:Reproductive Biology and Endocrinology
Subjects:
Luteinizing hormone
Recombinant luteinizing hormone
Assisted reproductive technology
In vitro fertilization
Advanced reproductive age
Online Access:https://doi.org/10.1186/s12958-021-00759-4

Internet

https://doi.org/10.1186/s12958-021-00759-4

Similar Items